Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury
Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury
复制标题
DOI:
10.1038/sj.bjp.0702549
复制
发表时间:
1999-05-01
影响因子:
7.3
通讯作者:
Plotkine, M
中科院分区:
文献类型:
--
作者:
Parmentier, S;Böhme, GA;Plotkine, M
1 The aim of this study was to investigate the effect of N-(3-(aminomethyl )benzyl)acetamidine (1400W), a selective inhibitor of inducible calcium-independent nitric oxide synthase (iNOS), on the functional and histopathological outcomes of experimental transient focal cerebral ischaemia in rats,2 Transient ischaemia was produced by the occlusion for 2 h of both the left middle cerebral artery and common carotid artery. Treatments with 1400W (20 mg kg(-1)) or vehicle were started 18 h after occlusion of the arteries and consisted in seven subcutaneous injections at 8 h interval. Isc haemic outcomes and NOS activities (constitutive and calcium-independent NOS) were evaluated 3 days Lifter ischaemia.3 1400W significantly reduced ischaemic lesion volume by 31%, and attenuated weight loss and neurological dysfunction.4 1400W attenuated the calcium-independent NOS activity in the infarct by 36% without affecting the constitutive NOS activity.5 These findings suggest that iNOS activation contributes to tissue damage and that selective inhibitors of this isoform may be of interest for the treatment of stroke.